Interact to see
Advertisement
Advertisement
CNRUX vs GFACX
CNRUX vs GFACX Comparison
Open Charts CNRUX vs GFACX
City National Rochdale US Cor Eq Instl
Price$27.70
Change+$0.11 (+0.40%)
VolumeN/A
Net Assets381.6M
American Funds Growth Fund of Amer C
Price$76.01
Change+$0.57 (+0.76%)
VolumeN/A
Net Assets340.58B
CNRUX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CNRUX vs. GFACX commentary
Oct 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNRUX is a Buy and GFACX is a Buy.
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 341B vs. CNRUX (382M). CNRUX pays higher dividends than GFACX: CNRUX (0.34) vs GFACX (0.00). CNRUX was incepted earlier than GFACX: CNRUX (13 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than CNRUX (0.57). GFACX is a more actively managed with annual turnover of: 25.00 vs. CNRUX (20.00). GFACX has a lower initial minimum investment than CNRUX: GFACX (250) vs CNRUX (1000000). GFACX annual gain was more profitable for investors over the last year : 12.54 vs. CNRUX (-2.43). GFACX (32.77) and CNRUX (31.49) have equivalent 5 years return.
| CNRUX | GFACX | CNRUX / GFACX | |
| Total Expense Ratio | 0.57 | 1.36 | 42% |
| Annual Report Gross Expense Ratio | 0.57 | 1.36 | 42% |
| Fund Existence | 13 years | 25 years | - |
| Gain YTD | 13.115 | 19.213 | 68% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 382M | 341B | 0% |
| Annual Yield % from dividends | 0.34 | 0.00 | - |
| Returns for 1 year | -2.43 | 12.54 | -19% |
| Returns for 3 years | 33.69 | 68.39 | 49% |
| Returns for 5 years | 31.49 | 32.77 | 96% |
| Returns for 10 years | 119.34 | 84.76 | 141% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NECCX | 14.82 | 0.02 | +0.14% |
| Natixis US Equity Opportunities C | |||
| VIMSX | 80.20 | N/A | N/A |
| Vanguard Mid Cap Index Investor | |||
| JFNCX | 61.87 | N/A | N/A |
| Janus Henderson Global Life Sciences C | |||
| BGLYX | 14.91 | N/A | N/A |
| Brookfield Global Listed InfrastructureI | |||
| BRWUX | 29.36 | N/A | N/A |
| MFS Blended Research Growth Eq R4 | |||